Research in animals shows MOTS c: Prevents fat accumulation Improves fat oxidation Enhances metabolic rate Reduces obesity associated insulin resistance Because it works at the cellular fuel level, fat loss from MOTS c is not cosmetic but metabolic
Evidence is also accumulating in Parkinsons disease, where GLP-1RAs have shown neuroprotective actions
Nacuitys molecules are differentiated, prescription-quality, GMP-grade moieties, which, combined with innovative delivery technologies, are poised to address diseases and conditions involving oxidative stress including retinitis pigmentosa, cataract and cystinosis as well as rare neurological diseases
Some researchers believe this decline may be connected to the reduced regenerative capacity many people notice as they get older
Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins